PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
XTLB XTL Biopharmaceuticals
- 1.740
- +0.080+4.82%
Close Feb 14 16:00 ET
15.34MMarket Cap-8.70P/E (TTM)
1.740High1.538Low3.33KVolume1.680Open1.660Pre Close5.44KTurnover0.04%Turnover RatioLossP/E (Static)8.81MShares4.99052wk High2.68P/B13.05MFloat Cap0.76852wk Low--Dividend TTM7.50MShs Float600.000Historical High--Div YieldTTM12.18%Amplitude0.625Historical Low1.635Avg Price1Lot Size
XTL Biopharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (Q2)Jun 30, 2016 | (FY)Dec 31, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 21.53%-707K | 14.11%-901K | -23.41%-1.05M | 6.39%-850K | -11.27%-908K | 27.47%-816K | 35.05%-1.13M | 6.93%-1.73M | 1.17%-508K | 24.66%-1.86M |
| Net income from continuing operations | -32.20%-1.78M | -409.89%-1.35M | 114.73%435K | -287.16%-2.95M | -121.02%-763K | 564.79%3.63M | 69.31%-781K | 40.96%-2.55M | -11.71%-477K | -50.47%-4.31M |
| Operating gains losses | 102.59%27K | -46.42%-1.04M | -134.95%-713K | 29,242.86%2.04M | 99.84%-7K | -480.24%-4.38M | -25,233.33%-754K | -99.57%3K | 91.67%-3K | 349.36%701K |
| Depreciation and amortization | --0 | 0.00%1K | 0.00%1K | --1K | --0 | --0 | --0 | ---- | -50.00%1K | -86.79%7K |
| Other non cash items | -13.89%-41K | -350.00%-36K | 75.76%-8K | 64.52%-33K | -6.90%-93K | -127.36%-87K | --318K | ---- | ---- | --6K |
| Change In working capital | 436.84%64K | 64.81%-19K | -220.00%-54K | 190.00%45K | -525.00%-50K | -115.38%-8K | 123.64%52K | -1,275.00%-220K | -74.24%-115K | 89.61%-16K |
| -Change in receivables | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -416.67%-114K | -101.92%-1K | 150.00%36K |
| -Change in prepaid assets | 80.00%45K | 180.65%25K | -234.78%-31K | 179.31%23K | -174.36%-29K | -81.34%39K | --209K | ---- | ---- | ---- |
| -Change in payables and accrued expense | 143.18%19K | -91.30%-44K | -204.55%-23K | 204.76%22K | 55.32%-21K | 70.06%-47K | -48.11%-157K | -103.85%-106K | 3.39%-114K | 81.29%-52K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 21.53%-707K | 14.11%-901K | -23.41%-1.05M | 6.39%-850K | -11.27%-908K | 27.47%-816K | 35.05%-1.13M | 6.93%-1.73M | 1.17%-508K | 24.66%-1.86M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 13.89%41K | 350.00%36K | -75.00%8K | -98.48%32K | 171.34%2.11M | 131.18%778K | -3,680.30%-2.5M | 40.00%-66K | 107.14%1K | -107.34%-110K |
| Net PPE purchase and sale | ---- | ---- | ---- | 50.00%-1K | ---2K | --0 | 150.00%1K | 0.00%-2K | ---- | 75.00%-2K |
| Net intangibles purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-64K | ---- | -3,100.00%-64K |
| Net business purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---55K |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | 186.93%2.02M | 128.16%704K | ---2.5M | --0 | ---- | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 108.33%1K | 450.00%11K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 13.89%41K | 350.00%36K | -75.00%8K | -98.48%32K | 171.34%2.11M | 131.18%778K | -3,680.30%-2.5M | 40.00%-66K | 107.14%1K | -107.34%-110K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0 | 385K | 0 | 0 | 4.89M | 0 | 1,058.25%3.58M | ||
| Net common stock issuance | ---- | ---- | ---- | ---- | ---- | ---- | --4.89M | --0 | ---- | 1,051.78%3.56M |
| Proceeds from stock option exercised by employees | --0 | --0 | --385K | --0 | --0 | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --20K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | --0 | --385K | --0 | --0 | ---- | --4.89M | --0 | ---- | 1,058.25%3.58M |
| Net cash flow | ||||||||||
| Beginning cash position | -29.47%2.09M | -18.23%2.97M | -18.50%3.63M | 36.87%4.46M | -1.03%3.26M | 62.90%3.29M | -47.11%2.02M | 76.79%3.82M | 77.35%3.11M | -25.22%2.16M |
| Current changes in cash | 23.01%-666K | -31.86%-865K | 19.80%-656K | -168.00%-818K | 3,265.79%1.2M | -102.99%-38K | 170.75%1.27M | -211.82%-1.8M | -116.73%-507K | 342.90%1.61M |
| Effect of exchange rate changes | -170.00%-27K | -66.67%-10K | 0.00%-6K | -100.00%-6K | -175.00%-3K | 300.00%4K | ---2K | ---- | -91.67%3K | 85.71%-2K |
| End cash Position | -33.09%1.4M | -29.47%2.09M | -18.23%2.97M | -18.50%3.63M | 36.87%4.46M | -1.03%3.26M | 62.90%3.29M | -47.11%2.02M | -45.95%2.61M | 76.79%3.82M |
| Free cash flow | 21.53%-707K | 14.11%-901K | -23.27%-1.05M | 6.48%-851K | -11.52%-910K | 27.47%-816K | 37.43%-1.13M | 6.69%-1.8M | 1.55%-508K | 22.30%-1.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | -- | -- | -- |
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!